Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SALE OF COMMON STOCK (Details Narrative)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands							9 Months Ended
	Oct. 02, 2018	May 01, 2018	Sep. 28, 2017	Apr. 13, 2017	Apr. 04, 2017	Mar. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Number of shares issued							54,000
Gross proceeds from stock issuance							$ 6,352	$ 17,387
Offering expenses							$ 172	$ 1,168
2017 Purchase Agreement [Member]
Number of shares issued							45,000
2017 Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued			15,000,000
Description of common stock sale requirement under applicable rule			<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">Under applicable rules of the NASDAQ Global Market, the Company could not issue or sell more than 19.99% of the shares of its common stock outstanding immediately prior to the execution of the 2017 Purchase Agreement (1.5 million shares) to Lincoln Park under the 2017 Purchase Agreement without stockholder approval, unless the average price of all applicable sales of its common stock to Lincoln Park under the 2017 Purchase Agreement equals or exceeds a threshold amount ($4.5178 per share). As the Company has issued 1.5 million shares to Lincoln Park under the 2017 Purchase Agreement at less than the threshold amount, the Company will not sell any additional shares under the 2017 Purchase Agreement without shareholder approval.</font></p>
Purchase Agreement and Registration Rights Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued			73,039
Addition number of shares issued			300,000
Sales Agreement [Member] \| Cowen and Company LLC [Member] \| Subsequent Event [Member]
Number of shares issued	3,300,000
Gross proceeds from stock issuance	$ 2,200
Net of expenses	$ 69
Sales Agreement [Member] \| Cowen and Company LLC [Member] \| At-The-Market Offering [Member]
Number of shares issued							1,600,000
Net proceeds from issuance of common stock		$ 9,500
Percentage of selling commission		3.00%
Underwriting Agreement [Member] \| Underwriters (2017 Underwriters) [Member] \| April 2017 Financing [Member]
Number of shares issued						1,800,000
Net proceeds from issuance of common stock					$ 7,200
Share price (in dollars per share)						$ 4.45
Underwriting discount					$ 600
Underwriting discount per share (in dollars per share)					$ 0.31
Offering expenses					$ 200
Percentage of underwriting discount					7.00%
Underwriting Agreement [Member] \| Underwriters (2017 Underwriters) [Member] \| Over-Allotment Option [Member]
Number of shares issued						270,000
April 2017 Financing [Member] \| Underwriters (2017 Underwriters) [Member] \| Over-Allotment Option [Member]
Number of shares issued				270,000
Net proceeds from issuance of common stock				$ 1,100
Underwriting discount				$ 100
Underwriting discount per share (in dollars per share)				$ 0.31